0001179110-15-016631.txt : 20151221 0001179110-15-016631.hdr.sgml : 20151221 20151221204146 ACCESSION NUMBER: 0001179110-15-016631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151217 FILED AS OF DATE: 20151221 DATE AS OF CHANGE: 20151221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE INC DATE OF NAME CHANGE: 19940719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mildenberger Laura CENTRAL INDEX KEY: 0001458379 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 151300595 MAIL ADDRESS: STREET 1: 601 HAWAII ST. CITY: EL SEGUNDO STATE: CA ZIP: 90245 4 1 edgar.xml FORM 4 - X0306 4 2015-12-17 1 0000927066 DAVITA HEALTHCARE PARTNERS INC. DVA 0001458379 Mildenberger Laura C/O DAVITA HEALTHCARE PARTNERS INC 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief People Officer Common Stock 2015-12-17 4 M 0 7300 43.35 A 14110 D Common Stock 2015-12-17 4 F 0 4645 68.13 D 9465 D Common Stock 2015-12-17 4 S 0 1242 68.1333 D 8223 D Common Stock 2015-12-17 4 M 0 2250 55.34 A 10473 D Common Stock 2015-12-17 4 F 0 1828 68.13 D 8645 D Common Stock 2015-12-17 4 S 0 198 68.15 D 8447 D Stock Appreciation Rights 43.35 2015-12-17 4 M 0 7300 0.00 D 2014-04-13 2016-04-13 Common Stock 7300 0 D Stock Appreciation Rights 55.34 2015-12-17 4 M 0 2250 0.00 D 2015-04-01 2017-12-18 Common Stock 2250 2250 D Represents the weighted average sale price of $68.1333. The range of prices for the sale of these shares was $68.13 - $68.15, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on 4/13/2011 and 50% vested each on 4/13/2014 and 4/13/2015. The Stock Appreciation Rights were granted on 12/18/2012 and 50% vested on 4/1/2015. Arturo Sida, Attorney-in-Fact 2015-12-21